4//SEC Filing
WP X Finance, L.P. 4
Accession 0001628280-19-010823
CIK 0001397702other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:03 PM ET
Size
142.9 KB
Accession
0001628280-19-010823
Insider Transaction Report
Form 4
WP X Finance, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
WPX GP, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
WARBURG PINCUS X PARTNERS, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
Warburg Pincus X, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
Warburg Pincus X LLC
10% Owner
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
WPP GP LLC
10% Owner
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
Warburg Pincus Partners, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
Warburg Pincus Partners GP LLC
10% Owner
Transactions
- Sale
Common Stock
2019-08-13$39.50/sh−630,000$24,885,000→ 7,406,301 total
Footnotes (5)
- [F1]Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), 610,470 shares were sold by WP X Finance, L.P. ("WP X Finance") and 19,530 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP") upon exercise of the underwriter's overallotment option.
- [F2]Pursuant to the Offering, on August 8, 2019, the Issuer, WP X Finance, WPXP, other selling stockholders, and the underwriters of the Offering (the "Underwriters"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,793,328 shares of common stock of the Issuer to the Underwriters, including an aggregate of 630,000 shares upon exercise of the Underwriters' overallotment option. The per share sale price reported in this Form 4 does not reflect underwriting discounts.
- [F3]7,176,711 of these shares are held by WP X Finance and 229,590 of these shares are held by WPXP.
- [F4]WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WP X and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners.
- [F5](continuation from footnote 3) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and may each be deemed to control the Warburg Pincus entities. Messrs. Kaye and Landy disclaim beneficial ownership of all shares held by the Warburg Pincus entities.
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001770767
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:03 PM ET
- Size
- 142.9 KB